FUNDING CHANGES. Bpifrance can accept Funding changes stipulated in the Master Agreement provided that they ensure continuation of the Project without altering its object and do not jeopardize the rates and maximum amounts of Funding as defined in Article 1.3. These changes are either presented by the Leader as part of the monitoring described in Article 2.2.1 or notified to Bpifrance pursuant to Article 2.6.1. Changes between lots from the same Beneficiary are implemented ipso jure when the financial impact of the change relative to the Calculation Base stipulated at Schedule 1, for each lot, is less than €[**] ([**] euros), cumulative since the last key milestone. The same changes between €[**] and €[**] inclusive, cumulative since the last key milestone, are submitted for authorization to Bpifrance. In all other cases, and particularly in the event of a change to the distribution of the Funding among the Beneficiaries, the change is subject to prior agreement by Bpifrance, and gives rise to the establishment of a rider to the Master Agreement and, if applicable, the Repayable Advance Beneficiary Agreement(s) in question and submission of a rider to the Partnership Agreements.
Appears in 2 contracts
Sources: Master Agreement (Gensight Biologics S.A.), Master Agreement (Gensight Biologics)